The Rheumatology Advanced Practice Providers (RhAPP)

Welcome to the Content Rheum! RhAPP is dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs).

Faculty

Wendy Simmons

PA-C

Carolina Arthritis Associates

Claudia Rivera Salas

NP

Lansing Rheumatology

Ingrid Pan

PharmD, BCPPS

University of Colorado

Christy Vath

PA-C

Seattle Rheumatology Associates Seattle, Washington

Jessica Farrell

PharmD

Albany Medical Center Division of Rheumatology Albany, New York

Heather Mambretti

PA-C

Texas Rheumatology

Robert Laugherty

JD, MBA, PA-C

East Tennessee Medical Group

Kyle George

PA-C

Boise, ID

Amanda Mixon

PA-C

UCHealth

Amber Hudgins

PharmD, SCP, CPP

Novant Health

Danielle Gatti-Palumbo

PharmD

Northwell Health Division of Rheumatology

Katie Springer

PA-C

Northwestern Medicine Lake Forest Hospital

Podcasts

Biosimilars and The Patient Perspective

RhAPPcast: Biosimilars Unveiled - Empowering APPs for Better Patient Conversations

RhAPPcast: The IL23/IL17 Cascade and Implications in the Pathogenesis of PsA, PsO, and IBD

IL-23

Provide Immunologic Rationale For IL23 Directed Therapy in PsA, PsO, and IBD.

What is The Role of IL23/IL17 Axis in Rheumatic Disease

Describe the IL23/IL17 Axis

Describe The Mechanism of Action of Guselkumab

Define, Compare, and Contrast Humoral and Cell-Mediated Immunity

What is Non-Responder Imputation and How is it Utilized in Clinical Trials

Data review from the Phase III Discover-2 Trials

Differentiation of Therapeutic Antibodies Targeting Interleukin (IL)-23

IL-17

What is the Safety Profile of Ixekizumab in PsA and axSpa

Provide Immunologic Rationale For IL17-Directed Therapy in PsA, AS, and nr-axSpA

Describe The Mechanism of Action of Ixekizumab

Describe the IL17-Induced Inflammatory Cascade

JAK

What is the safety profile of upadacitinib across indications?

Variability in JAK Inhibition Specificity & Its Clinical Implications

How is upadacitinib dosed across rheumatologic indications?

Describe the Mechanism of Action of Upadacitinib

Provide immunologic rationale for JAK directed therapy in rheumatic disease

Describe JAK-STAT signaling in inflammation

Biosimilars

What Does It Mean for a Biosimilar to Be Interchangeable and Why Is That Important?

What Does It Mean for a Biosimilar to Be Interchangeable and Why Is That Important?

Download the app and start using it now.

Download on the App Store

GET IT ON Google Play